Authors:
KRUCZYNSKI A
RICOME C
ASTRUC J
CHAZOTTES E
BERRICHON G
TARAYRE JP
COLPAERT F
HILL BT
Citation: A. Kruczynski et al., MARKED ANTITUMOR-ACTIVITY OF VINFLUNINE, A NEW FLUORINATED VINCA ALKALOID, IN MURINE AND HUMAN EXPERIMENTAL-TUMORS, Annals of oncology, 9, 1998, pp. 146-146
Authors:
KRUCZYNSKI A
COLPAERT F
TARAYRE JP
MOUILLARD P
FAHY J
HILL BT
Citation: A. Kruczynski et al., PRECLINICAL IN-VIVO ANTITUMOR-ACTIVITY OF VINFLUNINE, A NOVEL FLUORINATED VINCA ALKALOID, Cancer chemotherapy and pharmacology, 41(6), 1998, pp. 437-447
Authors:
KRUCZYNSKI A
BARRET JM
ETIEVANT C
COLPAERT F
FAHY J
HILL BT
Citation: A. Kruczynski et al., ANTIMITOTIC AND TUBULIN-INTERACTING PROPERTIES OF VINFLUNINE, A NOVELFLUORINATED VINCA ALKALOID, Biochemical pharmacology, 55(5), 1998, pp. 635-648
Citation: S. Tellez et al., ACETYLCHOLINE-RELEASE IN THE RAT PREFRONTAL CORTEX IN-VIVO - MODULATION BY ALPHA(2)-ADRENOCEPTOR AGONISTS AND ANTAGONISTS, Journal of neurochemistry, 68(2), 1997, pp. 778-785
Authors:
COSI C
COLPAERT F
KOEK W
DEGRYSE A
MARIEN M
Citation: C. Cosi et al., POLY(ADP-RIBOSE) POLYMERASE INHIBITORS PROTECT AGAINST MPTP-INDUCED DEPLETIONS OF STRIATAL DOPAMINE AND CORTICAL NORADRENALINE IN C57B1 6 MICE/, Brain research, 729(2), 1996, pp. 264-269
Citation: S. Tellez et al., THE ALPHA(2)-ADRENOCEPTOR ANTAGONIST, (-EFAROXAN, ENHANCES ACETYLCHOLINE-RELEASE IN THE RAT CORTEX IN-VIVO()), European journal of pharmacology, 277(1), 1995, pp. 113-116
Citation: M. Marien et al., NORADRENALINE DEPLETION EXACERBATES MPTP-INDUCED STRIATAL DOPAMINE LOSS IN MICE, European journal of pharmacology, 236(3), 1993, pp. 487-489